Muna farin cikin shiga cikin shugabannin masana'antu a CPHI Kudu maso Gabashin Asiya 2025, wanda ke faruwa daga Yuli 16 zuwa 18 a MITEC a Kuala Lumpur. Taron ya zagaya sama da murabba'in murabba'in 15,000 kuma zai ƙunshi masu nunin 400. Fiye da ƙwararrun 8,000 ana sa ran halartar, tare da 60+ taron karawa juna sani da taron da aka mayar da hankali kan yanayin masana'antu na yanzu, sabbin fasahohi, da ci gaban ka'idoji. Yana da kyakkyawar dama don haɗin kai da haɗin gwiwa a cikin sassan samar da magunguna.

Game da JYMed
 
JYMed babban kamfani ne mai mayar da hankali kan magunguna na peptide wanda ya kware a cikin bincike, haɓakawa, masana'antu, da kasuwanci. Muna ba da cikakken haɗin CDMO sabis wanda aka keɓance ga magunguna, kayan kwalliya, da abokan cinikin dabbobi a duk duniya.

Fayil ɗin mu ya ƙunshi kewayon APIs peptide. Kayayyakin tuta kamar Semaglutide da Tirzepatide sun yi nasarar kammala fassarori na FDA DMF na Amurka.

Reshen mu, Hubei JXBio, yana gudanar da layukan samar da peptide API na ci gaba da aka gina don saduwa da ka'idojin cGMP daga duka FDA ta Amurka da NMPA ta China. Wurin ya haɗa da manyan sikelin 10 da layin samar da matukin jirgi kuma ana samun goyan bayan ƙaƙƙarfan Tsarin Gudanar da Inganci (QMS) da ka'idojin Lafiya da Kare Muhalli (EHS).

JXBio ya wuce binciken GMP daga duka FDA ta Amurka da NMPA ta China. Muna alfaharin samun karɓuwa daga abokan haɗin gwiwar harhada magunguna na duniya don ƙware a cikin inganci, aminci, da bin muhalli.

BABBAN KAYANA

Tuntube Mu
Don tambayoyi, jin daɗin tuntuɓar:
● API na Duniya & Tambayoyin Kayan Kayan Aiki:+ 86-150-1352-9272
● Rijistar API & Ayyukan CDMO (Amurka & EU):+ 86-158-1868-2250
● Imel: jymed@jymedtech.com
● Adireshi:benaye 8 & 9, Ginin 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, China.